Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Clinical trial NCT02915302 · COMPLETED
Trial details
- NCT number
- NCT02915302
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-23
- Primary completion
- 2017-03-06
- Enrollment
- 1950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.